JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Home・Akcijų sąrašas・Danaher Corp

Search

Danaher Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

174.62 0.32

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

173.22

Max

176.42

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-168M 1B
Pardavimai	-887M 6B
P/E Sektoriaus vid.	34.936 67.147
Pelnas, tenkantis vienai akcijai	2.06
Dividendų pajamingumas	0.77
Pelno marža	17.291
Darbuotojai	58,000
EBITDA	-514M 1.5B

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+34.3% upside

Dividendai
By Dow Jones
Dividendų pajamingumas Sektoriaus vid.	0.77% 2.36%
Kitas uždarbis	2026-07-21
Kitas dividendų mokėjimo data	2026-07-24
Kita Ex Dividend data	2026-06-26

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-11B 128B
Ankstesnė atidarymo kaina	174.3
Ankstesnė uždarymo kaina	174.62

Naujienos nuotaikos

By Acuity

23%

77%

76 / 347 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

189.8851 / 196.5 Palaikymas ir pasipriešinimas

Danaher Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-21 11:36; UTC

Uždarbis

Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains -- Update

2026-04-21 11:00; UTC

Uždarbis

Danaher Raises Adjusted Earnings Guidance, 1Q Revenue, Profit Rise

2026-04-21 10:06; UTC

Uždarbis

Danaher 1Q Adjsuted Core Revenue Rose 0.5% >DHR

2026-04-21 10:05; UTC

Uždarbis

Danaher Sees 2Q Adjsuted Core Revenue Up Low-Single Digits >DHR

2026-04-21 10:05; UTC

Uždarbis

Danaher Still Sees 2026 Adjsuted Core Revenue Up 3%-6% >DHR

2026-04-21 10:05; UTC

Uždarbis

Danaher Had Seen 2026 Adjusted EPS $8.35-$8.50 >DHR

2026-04-21 10:04; UTC

Uždarbis

Danaher Raises 2026 View To Adj EPS $8.35-Adj EPS $8.55 >DHR

2026-04-21 10:04; UTC

Uždarbis

Danaher 1Q Operating Cash Flow $1.3B, Adjusted Free Cash Flow $1.1B >DHR

2026-04-21 10:00; UTC

Uždarbis

Danaher 1Q Cont Ops EPS $1.45 >DHR

2026-04-21 10:00; UTC

Uždarbis

Danaher 1Q Adj EPS $2.06 >DHR

2026-04-21 10:00; UTC

Uždarbis

Danaher 1Q Sales $5.95B >DHR

2026-04-21 10:00; UTC

Uždarbis

Danaher 1Q EPS $1.45 >DHR

2026-04-21 10:00; UTC

Uždarbis

Danaher 1Q Net $1.03B >DHR

2026-04-17 19:15; UTC

Rinkos pokalbiai

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

2026-04-17 19:07; UTC

Rinkos pokalbiai

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

2026-02-17 20:06; UTC

Įsigijimai, susijungimai, perėmimai

This Medical-Devices Stock Is Soaring. Danaher Is Buying the Company. -- Barrons.com

2026-02-17 15:14; UTC

Įsigijimai, susijungimai, perėmimai

Masimo Stock on Pace for Record Gains After Danaher Strikes Deal -- WSJ

2026-02-17 14:39; UTC

Įsigijimai, susijungimai, perėmimai

This Medical-Devices Stock Is Soaring. It's Being Bought by Danaher. -- Barrons.com

2026-02-17 13:30; UTC

Įsigijimai, susijungimai, perėmimai

This Medical-Devices Stock Is Soaring. It's Being Bought by Danaher. -- Barrons.com

2026-02-17 13:15; UTC

Įsigijimai, susijungimai, perėmimai

Danaher Strikes $10 Billion Deal for Masimo -- Update

2026-02-17 13:03; UTC

Įsigijimai, susijungimai, perėmimai

Danaher To Fund Masimo Acquisition With Cash on Hand, Debt Financing >DHR

2026-02-17 13:03; UTC

Įsigijimai, susijungimai, perėmimai

Danaher Sees More Than $125M Annual Cost Synergies, More Than $50M Annual Revenue Synergies by Fifth Full Year >DHR MASI

2026-02-17 13:02; UTC

Įsigijimai, susijungimai, perėmimai

Danaher Sees Masimo Deal Adding About 70c to Adjusted EPS in Fifth Full Year >DHR MASI

2026-02-17 13:02; UTC

Įsigijimai, susijungimai, perėmimai

Danaher Sees Masimo Deal Adding 15c-20c to Adjusted EPS in First Full Year >DHR MASI

2026-02-17 13:02; UTC

Įsigijimai, susijungimai, perėmimai

Masimo To Be Acquired By Danaher For $180.00 Per Share >MASI DHR

2026-02-17 13:01; UTC

Įsigijimai, susijungimai, perėmimai

Danaher to Buy Masimo for Total Enterprise Value of About $9.9 Billion >DHR MASI

2026-02-17 13:00; UTC

Įsigijimai, susijungimai, perėmimai

Danaher to Buy Masimo for $180/Share >DHR MASI

2026-02-17 13:00; UTC

Įsigijimai, susijungimai, perėmimai

Danaher To Acquire Masimo Corporation >DHR MASI

2026-02-17 11:09; UTC

Įsigijimai, susijungimai, perėmimai

Danaher Strikes $10 Billion Deal for Masimo -- WSJ

2026-02-17 11:09; UTC

Įsigijimai, susijungimai, perėmimai

Danaher Acquisition of Masimo Set to Be Announced Tuesday, Sources Say -- WSJ

Akcijų palyginimas

Kainos pokytis

Danaher Corp Prognozė

Kainos tikslas

By TipRanks

34.3% į viršų

12 mėnesių prognozė

Vidutinis 233.74 USD 34.3%

Aukščiausias 270 USD

Žemiausias 184.04 USD

Remiantis 16 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Danaher Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

16 ratings

14

Pirkti

2

Laikyti

0

Parduoti

Remiantis 16 analitikų, pateikusių Danaher Corp akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

189.8851 / 196.5Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

There is one bullish event.

The bullish and bearish events are balanced.

Rinkos nuotaikos

By Acuity

76 / 347 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Kitos sektoriaus akcijos

JNJ

Johnson and Johnson

225.57

UNH

UnitedHealth Group Inc

363.82

TMO

Thermo Fisher Scientific Inc

466.62

ISRG

Intuitive Surgical Inc

451.55

ABT

Abbott Laboratories

87.15

Live chat